Abstract
The major glomerular abnormalities in hypertensive nephrosclerosis are described as glomerular obsolescence (GO), glomerulosclerosis (GS), and glomerular collapse (GC). However, glomerular cellular changes caused by hypertensive insults have not been well analyzed. Using an immunoenzyme method, we examined eleven biopsy samples from patients with hypertensive nephrosclerosis for two synthetic and secreting phenotypes, α-smooth muscle actin (α-SMA) and collagen type III (Col. III), and two apoptotic phenotypes, pro-apoptotic molecule Bax and anti-apoptotic molecule Bcl-2. Together with the glomerular and vascular changes and interstitial fibrosis (IF) area, the results were scored quantitatively and semi-quantitatively and compared to the clinical findings, which included systolic blood pressure (SBP), mean arterial pressure (MAP), serum creatinine levels (sCr) and creatinine clearance (Ccr), using univariate and multivariate analyses. As a result, GS was frequently observed in the mild-to-moderate hypertensive group (140≤SBP<180 mmHg), whereas GC was positively correlated with SBP. Furthermore, there was a positive correlation of GS with mesangial α-SMA and Col. III, suggesting that GS was the reflection of these synthetic and secreting phenotypic changes in mesangial cells. Endothelial Bax was positively correlated with Ccr (p<0.01); in contrast, podocytic Bax was positively correlated with sCr (p<0.05) and showed a tendency to correlate with MAP (p=0.054). In conclusion, these findings support the view that mesangial synthetic and secreting phenotypic changes may be a reflection of cellular activation caused by mild-to-moderate hypertension and that apoptotic phenotypic expression in podocytes, rather than endothelial cells, may be related to the development of a severe form of hypertensive nephrosclerosis.
Similar content being viewed by others
Article PDF
References
Helmcben U, Wenzel UO : Benign and malignant nephrosclerosis and renovascular disease, in Tisher CC, Brenner BM : Renal Pathology. Philadelphia, Lippincott, 1994, pp 1201–1236.
Olson JL : Hypertension: essential and secondary forms, in Jennette JC, Olson JL, Schwartz MM, Silva FG : Heptinstall's Pathology of the Kidney, 5th ed. Philadelphia, Lippincott, 1998, pp 943–1001.
Nakaya H, Sasamura H, Kitamura Y, et al: Effects of angiotensin inhibitors on renal injury and angiotensin receptor expression in early hypertensive nephrosclerosis. Hypertens Res 1999; 22: 303–312.
Luft FC : Hypertensive nephrosclerosis: update. Curr Opin Nephrol Hypertens 2004; 13: 147–154.
Inada H, Ono H, Minami J, Ishimitsu T, Matsuoka H : Nipradilol prevents L-NAME–exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR. Hypertens Res 2002; 25: 433–440.
Rupprecht HD, Schocklmann HO, Sterzel RB : Glomerular mesangial cells, in Neilson EG, Couser WG : Immunologic Renal Disease, 2nd ed. Philadelphia, Lippincott, 2001, pp 657–691.
Sanders PW, Wang PX : Activation of the Fas/Fas ligand pathway in hypertensive renal disease in Dahl/Rapp rats. BMC Nephrol 2002; 3: 1.
Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z : Apoptosis in glomerular sclerosis. Kidney Int 1996; 49: 103–111.
Ono H, Ono Y, Takanohashi A, Matsuoka H, Frohlich ED : Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats. Hypertension 2001; 38: 1300–1306.
Ono H, Saitoh M, Ono Y, Ishimitu T, Matsuoka H : Imidapril improves L-NAME–exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats. J Hypertens 2004; 22: 1389–1395.
Ying WZ, Wang PX, Sanders PW : Induction of apoptosis during development of hypertensive nephrosclerosis. Kidney Int 2000; 58: 2007–2017.
Ying WZ, Sanders PW : Cytochrome c mediates apoptosis in hypertensive nephrosclerosis in Dahl/Rapp rats. Kidney Int 2001; 59: 662–672.
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure : The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–2446.
Fogo A, Breyer JA, Smith MC, et al, AASK Pilot Study Investigators : Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. Kidney Int 1997; 51: 244–252.
Takebayashi S, Kiyoshi Y, Hisano S, et al: Benign nephrosclerosis: incidence, morphology and prognosis. Clin Nephrol 2001; 55: 349–356.
Kritz W, Kobayashi N, Elger M : New aspects of podocyte structure, function, and pathology. Clin Exp Nephrol 1998; 2: 85–99.
Kretzler M, Koeppen-Hagemann I, Kriz W : Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat. Virchows Arch 1994; 425: 181–193.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kimura, N., Yonemoto, S., Machiguchi, T. et al. Synthetic/Secreting and Apoptotic Phenotypes in Renal Biopsy Tissues from Hypertensive Nephrosclerosis Patients. Hypertens Res 29, 573–580 (2006). https://doi.org/10.1291/hypres.29.573
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.573